157 related articles for article (PubMed ID: 11935317)
1. Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.
Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Hum Genet; 2002 Feb; 110(2):122-9. PubMed ID: 11935317
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.
Hakimi JM; Schoenberg MP; Rondinelli RH; Piantadosi S; Barrack ER
Clin Cancer Res; 1997 Sep; 3(9):1599-608. PubMed ID: 9815849
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
[TBL] [Abstract][Full Text] [Related]
5. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.
Irvine RA; Yu MC; Ross RK; Coetzee GA
Cancer Res; 1995 May; 55(9):1937-40. PubMed ID: 7728763
[TBL] [Abstract][Full Text] [Related]
6. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
[TBL] [Abstract][Full Text] [Related]
8. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490
[TBL] [Abstract][Full Text] [Related]
9. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk.
Kittles RA; Young D; Weinrich S; Hudson J; Argyropoulos G; Ukoli F; Adams-Campbell L; Dunston GM
Hum Genet; 2001 Sep; 109(3):253-61. PubMed ID: 11702204
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
Alptekin D; Izmirli M; Bayazit Y; Luleyap HU; Yilmaz MB; Soyupak B; Erkoc MA; Tansug Z
Genet Mol Res; 2012 May; 11(2):1424-32. PubMed ID: 22653589
[TBL] [Abstract][Full Text] [Related]
11. Lack of concordance and linkage disequilibrium among brothers for androgenetic alopecia and CAG/GGC haplotypes of the androgen receptor gene in Mexican families.
Arteaga-Vázquez J; López-Hernández MA; Svyryd Y; Mutchinick OM
J Cosmet Dermatol; 2015 Dec; 14(4):268-73. PubMed ID: 26178169
[TBL] [Abstract][Full Text] [Related]
12. Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer.
Paz-Y-Miño C; Robles P; Salazar C; Leone PE; García-Cárdenas JM; Naranjo M; López-Cortés A
Mol Med Rep; 2016 Aug; 14(2):1791-8. PubMed ID: 27357524
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
[TBL] [Abstract][Full Text] [Related]
15. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
[TBL] [Abstract][Full Text] [Related]
16. Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene.
Dietzsch E; Laubscher R; Parker MI
Int J Cancer; 2003 Oct; 107(1):38-45. PubMed ID: 12925954
[TBL] [Abstract][Full Text] [Related]
17. Association between androgen receptor polymorphic CAG and GGC repeat lengths and cryptorchidism: A meta-analysis of case-control studies.
Wang Y; Wei Y; Tang X; Liu B; Shen L; Long C; Lin T; He D; Wu S; Wei G
J Pediatr Urol; 2018 Oct; 14(5):432.e1-432.e9. PubMed ID: 29914823
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.
Balic I; Graham ST; Troyer DA; Higgins BA; Pollock BH; Johnson-Pais TL; Thompson IM; Leach RJ
J Urol; 2002 Nov; 168(5):2245-8. PubMed ID: 12394768
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia.
Biolchi V; Silva Neto B; Pianta DB; Koff WJ; Berger M; Brum IS
Mol Biol Rep; 2013 Mar; 40(3):2749-56. PubMed ID: 23184046
[TBL] [Abstract][Full Text] [Related]
20. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
Schildkraut JM; Murphy SK; Palmieri RT; Iversen E; Moorman PG; Huang Z; Halabi S; Calingaert B; Gusberg A; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):473-80. PubMed ID: 17372242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
